Seeking Alpha
Profile|
( followers)  

Selling, General and Administrative Expenses (most recently reported quarter) as a percentage of total revenue in the Biotech sector ranged from 844.3% (NASDAQ:ALXN) down to 7.0% (IMCL), with a median value of 42.3%.

* View More Biotech Sector Charts *

Data in table version -- click on a ticker for opinion and analysis of the company:

Total SG&A SG&A
Quarter Revenue Expense Margin
Ticker Company Ending ($mm) ($mm) (%)
AFFXAffymetrix Inc.12/31/05$86.39$30.30
35.1%
ALXNAlexion Pharmaceuticals Inc.10/31/05$0.77$6.48
844.3%
AMGNAmgen Inc.12/31/05$3217.00$911.00
28.3%
AMLNAmylin Pharmaceuticals Inc.12/31/05$82.35$57.07
69.3%
BIIBBiogen Idec Inc.12/31/05$611.18$162.02
26.5%
BMRNBioMarin Pharmaceutical Inc.12/31/05$13.81$11.08
80.2%
BSTEBiosite Incorporated12/31/05$79.33$19.83
25.0%
CELGCelgene Corporation12/31/05$181.84$58.08
31.9%
DNAGenentech Inc.03/31/06$1986.00$474.00
23.9%
ELNElan Corp. plc12/31/05$134.30$90.00
67.0%
GILDGilead Sciences Inc.03/31/06$692.88$149.71
21.6%
GPROGen-Probe Inc.12/31/05$86.26$18.09
21.0%
IMCLImclone Systems Inc.12/31/05$245.13$17.13
7.0%
INCYIncyte Corp.12/31/05$6.47$3.41
52.8%
ISTAISTA Pharmaceuticals Inc.12/31/05$3.68$8.66
235.2%
KOSPKOS Pharmaceuticals Inc.12/31/05$213.92$100.99
47.2%
MEDIMedImmune Inc.03/31/06$498.00$217.90
43.8%
NABINabi Biopharmaceuticals12/31/05$27.55$17.19
62.4%
NBIXNeurocrine Biosciences Inc.12/31/05$19.48$13.94
71.6%
ONXXOnyx Pharmaceuticals Inc.12/31/05N/A$17.76
N/A
PGNXProgenics Pharmaceuticals Inc.12/31/05$2.05$4.18
204.1%
PHRMPharmion Corp.12/31/05$56.59$23.14
40.9%
TELKTelik Inc.12/31/05N/A$2.74
N/A
VRTXVertex Pharmaceuticals Inc.12/31/05$39.09$12.81
32.8%

Data: Capital IQ

Related:

  1. Most recent opinion and analysis of Biotech stocks
  2. Full transcripts of recent conference calls in the Biotech sector
  3. Add the Biotech Stock Blog to your My Yahoo! page

Aside: Did you know that Seeking Alpha now publishes a daily recap of Jim Cramer's Mad Money stock picks?

Source: Chart: Biotech Stocks - SG&A Margin (MRQ)